Ligand profile
3L7
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_2316 — gpt
Identifiers
Database identifiers and provenance.
- Ligand ID
3L7- PDB
5kns- UniProt (similar protein)
P0A9M2- Target protein
- VK055_2316
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 191.1
- −1 ≤ LogP ≤ 5 -0.74
- MW ≤ 500 Da 437.3
- LogP ≤ 5 -0.74
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 11
- TPSA ≤ 140 Ų 191.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1nc2c(n1CCN(CCO/C=C/P(=O)(O)O)CCP(=O)(O)O)N=CNC2=Oc1nc2c(n1CCN(CCO/C=C/P(=O)(O)O)CCP(=O)(O)O)N=CNC2=O
InChI=1S/C13H21N5O8P2/c19-13-11-12(14-9-15-13)18(10-16-11)2-1-17(4-7-27(20,21)22)3-5-26-6-8-28(23,24)25/h6,8-10H,1-5,7H2,(H,14,15,19)(H2,20,21,22)(H2,23,24,25)/b8-6+InChI=1S/C13H21N5O8P2/c19-13-11-12(14-9-15-13)18(10-16-11)2-1-17(4-7-27(20,21)22)3-5-26-6-8-28(23,24)25/h6,8-10H,1-5,7H2,(H,14,15,19)(H2,20,21,22)(H2,23,24,25)/b8-6+
SGNFOZIWXPTVIN-SOFGYWHQSA-NSGNFOZIWXPTVIN-SOFGYWHQSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00156
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 3L7 →
- PDB RCSB structure 5kns →
- UniProt UniProt P0A9M2 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “3L7”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_2316.
PDB 14
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).